Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 137.3 M100.8 M98.8 M98.5 M 435.4 M Research & development ———— — Operating income -33.7 M55 M48.4 M-33.8 M 35.9 M Non-Operating Income, Total -3.6 M55.5 M-7.4 M23.8 M 68.3 M Interest expense, net of interest capitalized 89.6 M43.1 M42.7 M72.4 M 247.8 M Non-Operating Income, excl. Interest Expenses -64.6 M8.8 M-51.7 M-50.2 M -157.7 M Unusual income/expense -28.6 M3.6 M1.6 M1.6 M -21.8 M Pretax income -119.6 M67.4 M-1.7 M-85.3 M -139.2 M Equity in earnings 10.3 M——— — Taxes -19.6 M28.1 M-10.9 M-10 M -12.4 M Non-controlling/minority interest 300 K——— — After tax other income/expense ———— — Net income before discontinued operations -100.3 M39.3 M9.2 M-75.3 M -127.1 M Discontinued operations ———— — Net income -100.3 M39.3 M9.2 M-75.3 M -127.1 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -100.3 M37.7 M8.8 M-73 M -126.8 M Basic earnings per share (Basic EPS) -0.520.320.07-0.62 -0.75 Diluted earnings per share (Diluted EPS) -0.520.320.07-0.62 -0.75 Average basic shares outstanding 193.3 M118.6 M118.6 M118.4 M — Diluted shares outstanding 193.3 M118.8 M118.9 M118.4 M — EBITDA 291.6 M312.3 M240.2 M96.5 M 940.6 M EBIT 109.8 M198.8 M123.9 M-21 M 411.5 M Cost of revenue 2.15 B1.34 B1.32 B1.24 B 6.05 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 181.8 M113.5 M116.3 M117.5 M 529.1 M